Our top pick for
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our opinions or reviews. Learn how we make money.
Trupanion, Inc is an insurance—specialty business based in the US. Trupanion shares (TRUP) are listed on the NASDAQ and all prices are listed in US Dollars. Trupanion employs 738 staff and has a trailing 12-month revenue of around USD$434 million.
Since the stock market crash in March caused by coronavirus, Trupanion's share price has had significant positive movement.
Its last market close was USD$92.48, which is 64.42% up on its pre-crash value of USD$32.9 and 311.48% up on the lowest point reached during the March crash when the shares fell as low as USD$22.4752.
If you had bought USD$1,000 worth of Trupanion shares at the start of February 2020, those shares would have been worth USD$801.11 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth USD$2,848.38.
|Latest market close||USD$92.48|
|52-week range||USD$21.86 - USD$95.53|
|50-day moving average||USD$77.2147|
|200-day moving average||USD$50.5946|
|Wall St. target price||USD$62.4|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$0.046|
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2020-10-23)||23.47%|
|1 month (2020-10-01)||13.95%|
|3 months (2020-07-31)||82.88%|
|6 months (2020-05-01)||228.18%|
|1 year (2019-10-31)||290.21%|
|2 years (2018-10-31)||266.11%|
|3 years (2017-10-31)||228.41%|
|5 years (2015-10-30)||1,307.61%|
Valuing Trupanion stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Trupanion's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Trupanion's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 1850x. In other words, Trupanion shares trade at around 1850x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Trupanion's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$7.7 million.
The EBITDA is a measure of a Trupanion's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||USD$434 million|
|Operating margin TTM||0.49%|
|Gross profit TTM||USD$113 million|
|Return on assets TTM||0.51%|
|Return on equity TTM||1.2%|
|Market capitalisation||USD$3.3 billion|
TTM: trailing 12 months
There are currently 6.3 million Trupanion shares held short by investors – that's known as Trupanion's "short interest". This figure is 3% up from 6.1 million last month.
There are a few different ways that this level of interest in shorting Trupanion shares can be evaluated.
Trupanion's "short interest ratio" (SIR) is the quantity of Trupanion shares currently shorted divided by the average quantity of Trupanion shares traded daily (recently around 755307.34939759). Trupanion's SIR currently stands at 8.3. In other words for every 100,000 Trupanion shares traded daily on the market, roughly 8300 shares are currently held short.
However Trupanion's short interest can also be evaluated against the total number of Trupanion shares, or, against the total number of tradable Trupanion shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Trupanion's short interest could be expressed as 0.18% of the outstanding shares (for every 100,000 Trupanion shares in existence, roughly 180 shares are currently held short) or 0.1944% of the tradable shares (for every 100,000 tradable Trupanion shares, roughly 194 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Trupanion.
Find out more about how you can short Trupanion stock.
We're not expecting Trupanion to pay a dividend over the next 12 months.
Over the last 12 months, Trupanion's shares have ranged in value from as little as $21.86 up to $95.53. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Trupanion's is 1.5306. This would suggest that Trupanion's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Trupanion, Inc., together with its subsidiaries, provides medical insurance for cats and dogs on monthly subscription basis in the United States, Canada, and Puerto Rico. The company operates through Subscription Business and Other Business segments. It serves pet owners and veterinarians through third-party referrals and online member acquisition channels. The company was formerly known as Vetinsurance International, Inc. changed its name to Trupanion, Inc. in 2013. Trupanion, Inc. was founded in 2000 and is headquartered in Seattle, Washington.
Everything we know about the EZGO Technologies IPO, plus information on how to buy in.
Everything we know about the NeoGames IPO, plus information on how to buy in.
Everything we know about the Genius Sports Group Ltd IPO, plus information on how to buy in.
Everything we know about the Meat-Tech 3D IPO, plus information on how to buy in.
Everything we know about the Monday.com IPO, plus information on how to buy in.
Everything we know about the Maravai LifeSciences Holdings IPO, plus information on how to buy in.
Everything we know about the WeWork IPO, plus information on how to buy in.
Steps to owning and managing RAVN, with 24-hour and historical pricing before you buy.
Steps to owning and managing NBIX, with 24-hour and historical pricing before you buy.
Steps to owning and managing KTB, with 24-hour and historical pricing before you buy.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.